HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis

Journal of Rheumatology

Volumn 29, Issue 11, 2002, Pages 2319-2326

  Maksymowych, Walter P ^a   Suarez Almazor, Maria E ^a   Buenviaje, Heidi ^a   Cooper, Bobbi Lynn ^a   Degeus, Caroline ^a   Thompson, Michael ^a   Russell, Anthony S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

HLA genes; Palindromic rheumatism; Rheumatoid arthritis

Indexed keywords

CYTOKINE; GENOMIC DNA; HLA DR3 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 4; RESTRICTION ENDONUCLEASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTHROPATHY; ARTICLE; CHRONIC DISEASE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE DOSAGE; GENOTYPE; HOMOZYGOSITY; HUMAN; IMMUNOGENETICS; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PALINDROMIC RHEUMATISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK FACTOR;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CYTOKINES; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; EPITOPES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROMOTER REGIONS (GENETICS); RHEUMATIC DISEASES;

EID: 0036843171     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hench JJ, Rosenberg EF. Palindromic rheumatism. Arch Intern Med 1994;73:293-321.
2. Hannonen P, Mottonen T, Oka M. Palindromic rheumatism, a clinical survey of sixty patients. Scand J Rheumatol 1987;16:413-20.
3. Mattingly S. Palindromic rheumatism. Ann Rheum Dis 1966;25:307-17.
4. Williams MH, Sheldon PJHS, Torrigiani G, Eisen V, Mattingly S. Palindromic rheumatism. Clinical and immunological studies. Ann Rheum Dis 1971;30:375-80.
5. Wajed MA, Brown DL, Currey HLF. Palindromic rheumatism. Clinical and serum complement study. Ann Rheum Dis 1977;36:56-61.
6. Eliakim A, Neumann L, Horowitz J, Buskila D. Kleiner-Baumgarten A, Sukenik S. Palindromic rheumatism in Israel: A disease entity? A survey of 34 patients. Clin Rheumatol 1989;8:507-11.
7. Youssef WA, Yan A, Russell AS. Palindromic rheumatism: A response to chloroquine. J Rheumatol 1991;18:35-7.
8. Gonzalez-Lopez L, Gamez-Nava JI, Jhangri GS, Ramos-Remus C, Russell AS, Suarez-Almazor ME. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. J Rheumatol 1999;26:540-5.
9. Bregeon C, Dajon JL, Renier G, et al. Palindromic rheumatism. Immunologic survey and study of development in 43 cases. Rev Rhum Mal Osteoartic 1986;53:441-9.
10. Barbieri P, Ciompi ML, Menicucci A, Pasero G. HLA antigens in palindromic rheumatism. An Italian study. Clin Rheumatol 1988;7:470-3.
11. Fisher LR, Kirk A, Awad J, et al. HLA antigens in palindromic rheumatism and palindromic onset rheumatoid arthritis. Br J Rheumatol 1986;25:345-8.
12. Gran JT, Husby G, Thorsby E. HLA antigens in palindromic rheumatism, nonerosive rheumatoid arthritis and classical rheumatoid arthritis. J Rheumatol 1984;11:136-40.
13. Thomson W, Harrison B, Ollier B, et al. Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis. Arthritis Rheum 1999;42:757-62.
14. De Jongh BM, van Romunde LKJ, Valkenburg HA, de Lange GG. Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population. Ann Rheum Dis 1984;43:613-9.
15. Weyand CM, Xie C, Goronzy JJ. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992;89:2033-9.
16. Hall FC, Weeks DE, Camilleri JP, et al. Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. Q J Med 1996;89:821-9.
17. Meyer JM, Evans TI, Small RE, et al. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis. J Rheumatol 1999;26:1024-34.
18. Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-6.
19. Wordsworth P, Pile K, Buckely J, et al. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 1992;51:585-91.
20. Jawaheer D, Thomson W, MacGregor AJ, et al. "Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum 1994;37:681-6.
21. Rau R, Herborn G, Zueger S, Fenner H. The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years. J Rheumatol 2000;27:2566-75.
22. Suarez-Almazor ME, Tao S, Moustarah F, Russell AS, Maksymowych W. HLA-DR1, DR4 and DRB1 disease related subtypes in rheumatoid arthritis: Association with susceptibility but not severity in a city wide community based study. J Rheumatol 1995;22:2027-37.
23. Vos K, van der Horst-Bruinsma IE, Hazes JMW, et al. Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis. Rheumatology 2001;40:133-9.
24. Reviron D, Perdriger A, Toussirot E, et al. Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis Rheum 2001;44:535-40.
25. Cantagrel A, Navaux F, Loubet-Lescoulie P, et al. Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: Relation to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999;42:1093-100.
26. van Krugten MV, Huizinga TW, Kaijzel EL, et al. Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritis. Genes Immunol 1999;1:91-6.
27. Pasero G, Barbieri P. Palindromic rheumatism: You just have to think about it! Clin Exp Rheumatol 1986;4:197-9.
28. Guerne PA, Weisman MH. Palindromic rheumatism: Part or apart from the spectrum of rheumatoid arthritis. Am J Med 1992;93:451-60.
29. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
30. Van Jaarsveld CHM, Otten HG, Jacobs JWG, Kruize AA, Brus HLM, Bijlsma JWJ. Association of HLA-DR with susceptibility to and clinical expression of rheumatoid arthritis: Re-evaluation by means of genomic tissue typing. Br J Rheumatol 1998;37:411-6.
31. Rønningen KS, Spurkland A, Egeland T, et al. Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residue 67-74. Tissue Antigens 1990;36:236-40.
32. Combe B, Dougados M, Goupille P, et al. Prognostic factors for radiographic damage in early rheumatoid arthritis. Arthritis Rheum 2001;44:1736-43.
33. Gough A, Faint J, Salmon M, et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994;37:1166-70.
34. El-Gabalawy HS, Goldbach-Mansky R, Smith D II, et al. Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum 1999;42:1696-705.
35. Harrison B, Thomson W, Symmons D, et al. The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis. Arthritis Rheum 1999;42:2174-83.
36. Mattey DL, Hassell AB, Dawes PT, et al. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2001;44:1529-33.
37. Lard LR, Boers M, Verhoeven A, et al. Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage. Arthritis Rheum 2002;46:899-905.
38. Avina-Zubieta JA, Galindo-Rodriguez G, Newman S, Suarez-Almazor ME, Russell AS. Long-term effectiveness of antimalarial drugs in rheumatic diseases. Ann Rheum Dis 1998;57:582-7.
39. D'Alfonso S, Momigliano RP. An intragenic polymorphism in the human tumor necrosis factor alpha (TNFA) chain-encoding gene in Japanese. Immunogenetics 1996;44:321-2.
40. Verweij CL. Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis. Ann Rheum Dis 1999;58 Suppl 1:120-6.